Harrow, Inc.
HROW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001360214
In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Harrow, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −3 vs. Q1 2021
- Shares held
- 13.7M
- −1.34M (−8.9%) vs. Q1 2021
- Total value
- $125.7M
- +$24.7M (+24.4%) vs. Q1 2021
- New holders
- 20
- 30 more added
- Sold out
- 23
- 25 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 223 | $912.6M |
| Q1 2026 | 219 | $755.6M |
| Q4 2025 | 215 | $1.09B |
| Q3 2025 | 197 | $1.02B |
| Q2 2025 | 161 | $643.3M |
| Q1 2025 | 157 | $551.3M |
| Q4 2024 | 166 | $699.0M |
| Q3 2024 | 159 | $939.9M |
| Q2 2024 | 110 | $397.6M |
| Q1 2024 | 112 | $273.2M |
| Q4 2023 | 113 | $255.7M |
| Q3 2023 | 129 | $358.7M |
| Q2 2023 | 112 | $437.6M |
| Q1 2023 | 115 | $442.7M |
| Q4 2022 | 96 | $266.6M |
| Q3 2022 | 81 | $184.5M |
| Q2 2022 | 88 | $136.6M |
| Q1 2022 | 80 | $103.5M |
| Q4 2021 | 77 | $131.0M |
| Q3 2021 | 79 | $131.3M |
| Q2 2021 | 90 | $125.7M |
| Q1 2021 | 93 | $101.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Harrow, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Oak Wealth Management Inc | 0 | $0 | 0.00% | −19,770−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −16,129−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −13,606−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −13,044−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,182−100.0% | Sold out |
| AMP Capital Investors Ltd | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Cardan Capital Partners, LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,599−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,977−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,482−100.0% | Sold out |
| Certified Advisory Corp | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −667−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |